Grants for For profit organizations other than small businesses - Health

The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage Financial Info: The COVID-19 Vaccine Outreach Grant Program supports the efforts of local organizations in Pennsylvania conducting grassroots outreach to communities about COVID-19 vaccines. Organizations will work to educate their communities on COVID-19 vaccines to improve usage of the vaccine, and overall, the health and safety of Pennsylvania. This program will engage and provide the necessary funding to community organizations to educate their community regarding COVID-19 vaccination to address hesitancy concerns and barriers. The COVID-19 Vaccine Outreach Grant Program is a federally funded program. Applicants will need a Data Universal Number System (DUNS) number in order to apply for funding and be registered with the System for Award Management (SAM) in order to receive funding under the program. To register for a DUNS number please visit Dun & Bradstreet website. To obtain a SAM number, visit the SAM website. Dun & Bradstreet website SAM website For general questions about the program, reporting, reimbursement, or outreach efforts in Philadelphia, visit the Vaccine Outreach Grant Program Frequently Asked Questions webpage. Vaccine Outreach Grant Program Frequently Asked Questions webpage

The COVID-19 Relief – Supporting Elm and Main (SEAM) program will provide financial assistance to the community revitalization organizations dedicated to community and economic development in older and historic downtowns, commercial districts, and neighborhoods according to the principles of the Elm Street and Main Street Approaches. The program, supported by Keystone Communities funding, is intended to assist Elm Street and Main Street organizations that have been economically impacted by COVID-19. Financial Info: The COVID-19 Relief – Supporting Elm and Main (SEAM) program will provide financial assistance to the community revitalization organizations dedicated to community and economic development in older and historic downtowns, commercial districts, and neighborhoods according to the principles of the Elm Street and Main Street Approaches. The program, supported by Keystone Communities funding, is intended to assist Elm Street and Main Street organizations that have been economically impacted by COVID-19.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development intends to publish a Notice of Funding Opportunity (NOFO) to invite applications to establish integrated and collaborative Stillbirth Research Centers, as part of a new Stillbirth Research Consortium. The Centers will support cutting-edge basic, translational, clinical, and/or data sciences research and generate knowledge to fuel advancement of stillbirth-relevant research in the United States, with a particular emphasis on approaches that utilize an equity lens to identify ways to decrease the incidence of stillbirth in vulnerable populations. A Data Coordinating Center (described in the companion announcement NOT-HD-24-010) will support the work of the research projects funded under the Stillbirth Research Consortium. This Notice is being provided to allow potential applicants additional time to develop meaningful collaborations, interdisciplinary teams, and responsive applications. International collaboration is encouraged and allowable. The NOFO is expected to be published in Summer 2024 with an expected application due date in Winter 2024. This NOFO will utilize the UG1 activity code. Details of the planned NOFO are provided below.

The National Institute of Neurological Disorders and Stroke (NINDS), intends to publish a reissue Notice of Funding Opportunity (NOFO) to solicit applications for innovative, interactive research to answer significant scientific questions that are important for the mission of NINDS, via a synergistic collaboration between outstanding scientists who might not otherwise collaborate. The program project grant is designed to support research in which the funding of several interdependent highly meritorious projects as a group offers significant scientific advantages over support of these same projects as individual research grants.. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in April 2024 with an expected application due dates in May and September 2024. NINDS will not have any receipt dates after September 2024, thus ending the program. This NOFO will utilize the P01 activity code. Details of the planned NOFO are provided below.

This funding opportunity supports collaborative cancer prevention and education programs in Indiana, specifically targeting high-burden cancers and underserved communities, with a focus on reducing risk behaviors and improving health outcomes.

This program provides $145 million in financial assistance to hospitality businesses impacted by the COVID-19 pandemic through county-established grant programs.

The Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law on March 27, 2020. The $2 trillion economic relief package aims to protect the American people from the public health and economic impacts of COVID-19. Act 2A of 2020, known as the COVID-19 Emergency Supplement to the General Appropriation Act of 2019, appropriated $10,000,000 from the COVID-19 Response Restricted Account to the Department of Health. Through a sub-grant, the Department of Community and Economic Development will administer this program to eligible applicants for the rapid advancement of vaccines, treatments, and therapies in response to COVID-19. Financial Info: The Coronavirus Aid, Relief, and Economic Security (CARES) Act was signed into law on March 27, 2020. The $2 trillion economic relief package aims to protect the American people from the public health and economic impacts of COVID-19. Act 2A of 2020, known as the COVID-19 Emergency Supplement to the General Appropriation Act of 2019, appropriated $10,000,000 from the COVID-19 Response Restricted Account to the Department of Health. Through a sub-grant, the Department of Community and Economic Development will administer this program to eligible applicants for the rapid advancement of vaccines, treatments, and therapies in response to COVID-19.

This ISO seeks solution summary and proposal submissions for projects that fall within the scope of the ARPA-H mission Resilient Systems Office (RSO). RSOs interest areas will address systemic challenges across the healthcare and public health landscape by investing in cutting-edge technologies that address long-standing gaps in the quality, efficacy, and consistent availability of care.Aspects of todays health and public health systems remain fragile due to systemic challenges, which include rising healthcare costs, inadequate healthcare coverage for significant populations, outdated infrastructure, and health disparities among different demographic groups. Acute challenges, such as hospital closures, supply chain disruptions, staffing shortages, cyber-attacks, public health crises, and the emergence of new diseases, further exacerbate existing fragilities, making it more difficult to maintain high standards of care. These challenges are compounded by the fact that systems remain fragmented, hindering the ability to gain comprehensive insights, make informed decisions, develop tailored interventions, and share critical health information between stakeholders.RSO seeks solution summaries and proposals that drive innovations to enhance the adaptability, reliability, and interoperability of the health ecosystem. Of interest are innovations that foster flexibility and enable adaptation to system stressors, so that people and systems remain well-positioned to deliver high-quality care and improve health outcomes. The following interest areas categorize the ground-breaking research we seek to support:Sociotechnical System Innovation: Innovate user-centric digital health tools, platforms, technologies, and intervention models that improve outcomes across the health continuum, including prevention, diagnosis, and treatment of physical, mental, and behavioral health. Approaches to build trust in the healthcare system and distribute high-quality health guidance in an understandable manner that improves patient outcomes. Novel real-time measurement tools to track health outcomes, evaluate post-market performance of new interventions, and enable convergence on the most effective strategies to improve the quality of care, especially for underserved communities. Other population centered innovations to create more resilient communities and subpopulations. Innovations might include aggregate improvements to quality of care and better physical, mental, and behavioral health outcomes for the health ecosystem.Health Ecosystem Integration: Novel ways to collect, protect, secure, integrate, analyze, communicate, and present health data, including but not limited to advances in privacy, cyber security, artificial intelligence with enhanced patient safety properties, low-code or no-code technologies, semantic approaches, and rapid integration techniques. Strategies and technologies to leverage homes, community centers, pharmacies, and other accessible locations to enable new modalities of high-quality care, expand the reach of clinical research, or integrate end-user feedback to rapidly iterate prototype designs. Approaches to strengthen the connectivity and interoperability of health data and devices to 5 enable the safe, secure, and seamless exchange of information among healthcare providers, researchers, and stakeholders. Other novel approaches to increase the interoperability of health-related systems in support of improved health outcomes and enhanced transparency across the health ecosystem.Adaptive Antifragile Solutions: Creative approaches to enhance the stability and dependability of the health ecosystem through new adaptive paradigms, methods that anticipate and mitigate disruptions before they occur, and enhancements to emergency response. Approaches that enable health infrastructure to rapidly integrate information from new sensors; create decision support tools; adapt supply chains, manufacturing, and logistics; and better leverage the workforce during public health emergencies. Novel methods to engineer resilient tissues, microbiomes, and biophysical systems to combat disease or maintain health. Other novel approaches to enhance adaptability and reduce fragility within the health ecosystem.Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, systems, or methodology. Specifically excluded are proposals that represent an evolutionary or incremental advance in the state of the art or technology that has reached the clinical trial stage. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission

Despite huge advances in the development of novel medical therapies, Americans still live with poor health outcomes and suffer from the ill-effects of disease. Current medical research and the medical delivery system in the United States focus primarily on the reactive treatment of illnesses, despite the fact that many diseases or their ill-effects are preventable.The Proactive Health Office (PHO) at ARPA-H is seeking solutions to improve the healthspan and health outcomes of Americans prior to the onset of disease and/or the development of diminished quality of life from illness. Specifically, PHO hypothesizes that 1) population-level improvements in access to and uptake of disease prevention and wellness-promoting behaviors and 2) development of novel early-detection methods and prophylactic interventions could drastically improve the health of American throughout their lives, and 3) that system level innovations are required for delivery of proactive health effectively. Specific PHO interest areas include:Novel prevention, detection and prophylactic treatment methods for disease: Novel and scalable methods for early detection of disease and illness including the use of low/no-cost sensing modalities. Prophylactic approaches to prevention of diseases and harmful disease outcomes. Methods for continuous and widespread sensing of health state and early disease indicators that can be deployed at population-scale.Population-level approaches to increase the adoption of prevention and wellness behaviors: Early indicators of disease and pre-disease states and measures associated with proactive health outcomes that are both inexpensive and effective. Low-cost, high-uptake mental health resiliency and mindfulness building methods for individuals. Methods to inform and educate individuals about healthy behaviors including lifestyle and preventative medical measures. Methods that incentivize individuals to adopt and maintain healthy behaviors. Novel approaches to increasing individual healthspan and independence even in the absence of disease.System innovation for the delivery of proactive health outcomes: Novel, robust and predictive surrogates for long-term health outcomes with associated epidemiological models. Valuation models for long-term treatment effects for vaccination, screening and other public health interventions. New funding and delivery models for preventative intervention.Other high-quality submissions that propose revolutionary technologies that meet the goals of PHO will be considered even if they do not address the topics listed above.Proposals are expected to use innovative approaches to enable revolutionary advances in medicine and healthcare, and the science and technology underlying these areas. While approaches that are disease agnostic are encouraged, ARPA-H welcomes proposals that bring radically new insights to address specific diseases including, but not limited to, cancer, diabetes, neurological diseases, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.Specifically excluded are proposals that represent an evolutionary or incremental advance in the current state of the art or technology that has reached the clinical trial stage. An example of this type of proposal might include the request to fund clinical trials of an otherwise developed product. Additionally, proposals directed towards policy advocacy, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission.

This ISO seeks solution summaries and proposal submissions for projects that fall within the general scope of the ARPA-H Health Science Futures (HSF) mission office. HSF expands what is technically possible by developing approaches that will remove the scientific and technological limitations that stymie progress towards the healthcare of the future. HSF supports cutting-edge, often disease-agnostic research programs that have the potential for translational real-world change.Considering the current healthcare challenges that we face today, the goal of achieving better health outcomes is a moving target that requires daring and adaptable solutions. HSF awardees will develop innovative technologies, tools, and platforms that can be applied to a broad range of diseases. The following interest areas define the ground-breaking research we seek to support:Breakthrough Technologies: Paradigm shifting technologies that will change how we approach the diagnosis, treatment, and impact of diseases and conditions. Novel approaches to improve maternal and fetal medicine, decrease maternal morbidity and mortality during birth, and the post-partum period. Efforts should include new technology to monitor, detect, and/or treat maternal and/or fetal complications with less invasive and traumatic methods. Foundational advances in genetic, epigenetic, cellular, tissue, and organ replacement therapies that enable personalized medical interventions at scale in a manner that is accessible, cost-effective, and designed to impact the communities of greatest need. Interventions that target and reverse disease pathogenesis and/or enhance plasticity to address diseases of the nervous, neuromuscular, skeletal, lymphatic, cardiovascular, and other organ systems. Novel approaches to diagnose and treat diseases of the lymphatic system, particularly rare diseases, with a focus on the effects of genetic expression in the lymphatic system and/or models demonstrating the relationship between lymphatic dysfunction and health and disease.Transformative Tools: Novel, agile solutions that will move from bench to bedside quickly, facilitating revolutionary advances in medical care. Development of tools that counter idiosyncratic, off-target, or chronic effects of medicines that are commonly used or that are being used experimentally to treat or prevent disease. Development of bionics to restore sight, hearing, taste, or smell. Site-selective neuromodulation to regulate specific physiological functions and treat chronic health conditions such as inflammation, pain, and metabolic or endocrine disorders. Synthetic biology approaches to diagnosing, treating, and/or curing a multitude of diseases. Novel physics and/or chemistry-based approaches to improve imaging that reduces cost, increases availability, expands capability, improves resolution, reduces exposure to radiation, and accommodates pediatric patient populations. Integrated sensing and delivery devices for treating and diagnosing chronic health conditions, including mental health conditions or substance use disorders. Miniaturization of complex hardware to enable broader access to pediatric and other patient populations, as well as portability, such as diagnostic, treatment, imaging, or other devices.Platform Systems: Adaptable, multi-application systems and technologies that are reconfigurable for a wide variety of clinical needs Novel molecular platform approaches, including the modulation of host systems, delivery to targets with spatial and temporal precision, and mitigation of off-target effects to accelerate interventions that dramatically improve health outcomes. New approaches to accelerate and routinize mammalian and microbial cellular engineering to enable next generation therapeutic applications, develop multiscale interventions, and automate hypothesis generation and discovery to expand those applications to disease states in which cellular therapies have not traditionally been employed. Innovative approaches at the intersection of artificial intelligence, high performance computing (including quantum computing) and biological systems, including enabling de novo design of biomolecules with entirely new phenotypes.Other high-quality submissions that propose revolutionary technologies that meet the goals of HSF will be considered even if they do not address the topics listed above.Proposals are expected to use innovative approaches to enable revolutionary advances in medicine and healthcare, and the science and technology underlying these areas. While approaches that are disease agnostic are encouraged, ARPA-H welcomes proposals that bring radically new insights to address specific diseases including, but not limited to, cancer, diabetes, neurological diseases, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.Specifically excluded are proposals that represent an evolutionary or incremental advance in the current state of the art or technology that has reached the clinical trial stage. An example of this type of proposal might include the request to fund clinical trials of an otherwise developed product. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission.

This ISO seeks solution summaries and proposals for projects that fall within the general scope of the ARPA-H Scalable Solutions mission office. SSO expands what is technically possible by developing approaches that will leverage an interdisciplinary approach and collaborative networks to address challenges of geography, distribution, manufacturing, data and information, thereby improving health care access and affordability. In the United States, many communities and remote areas lack access to timely and quality health care, which leads to disparities in health outcomes for those populations. Bottlenecks during the manufacturing processes of products and health technologies also lead to delays and limited availability, preventing effective distribution of health care solutions to areas of need, especially in emergencies.ARPA-H SSO seeks solutions to improve the scalability and affordability of health care solutions, bridge gaps in underserved areas, and extend remote access to expertise by developing location-specific interventions, telemedicine solutions, and mobile health clinics. Solutions should focus on rapid innovation and the use of partnerships, as well as flexible distribution networks and streamlined manufacturing processes. The following SSO interest areas categorize the ground-breaking solutions we seek to support:Scalable Technologies and Interventions: Approaches to improve affordability and equitable access to health care that are adaptable to various geographic, demographic, economic contexts and can be rapidly deployed at scale (e.g., drug-repurposing*, telemedicine, point-of-care diagnostics, and modular health care infrastructure). Tailored solutions for the pediatric population that provide parity in access to treatments and other health care interventions with the adult population and adapt to the pediatric patients changing physiology and developmental status over the course of years. Transformational approaches to reduce or eliminate health disparities, including tools and models for product design and care delivery that scale novel approaches in human factors and human-centered design to respond to full diversity of patients. Tools to enable the scaling of provider and institutional capabilities (e.g., school nurses and schools, walk-in clinics, homesteading care) to address unmet health care access needs and expand availability of critical services. Foundational capabilities to accelerate diagnoses and reduce the cost of treatments for rare diseases wherever patients are, without the need for specialized facilities or healthcare expertise.* Solution summaries and proposals that focus on testing drugs for effectiveness for other disease states or use cases, are unlikely to be funded unless including additional R, or providing gains in cost reduction, accessibility, and/or equity.Collaborative Distribution Networks: Methods for standardization, automation, and democratization of complex procedures 5 including, but not limited to, histopathology, rare disease diagnosis and treatment, and surgical interventions to ensure access and delivery to populations diverse in demographics, geographies, and resources at scale. Approaches to enhance delivery of effective healthcare solutions in rural or low resource settings, including but not limited to "last mile delivery, at-home monitoring, imaging, drug delivery, telehealth augmentation, and support for remote medical procedures with limited need for specialized training. Technologies to enable the deployment of critical healthcare resources rapidly, equitably, and securely at scale to the point of need in permissive and non-permissive (i.e., damaged infrastructure, cyber-denied) environments during a public health crisis or natural disaster. Solutions to scale education and training of critical healthcare resources for health care providers and patients to ensure information integrity to prevent negative impacts to resource use/uptake. Innovative information technology, data and analytic products and technologies to enable ordering, inventory management, situational awareness, allocation planning and demand forecasting of critical healthcare resources during a public health crisis or natural disaster.Biomanufacturing Innovations*: Innovative manufacturing technologies and approaches that reduce cost, shorten the timeline for production, advance domestic competitiveness and reduce supply chain risk of biologics, cellular and gene therapies, pharmaceuticals, medical devices and personal protective equipment. New approaches to support predictable, programable biological production of conventional and novel materials reliability at scale in a cost-effective sustainable manner. Novel solutions to reduce the reliance on specialized handling and cold chain management of pharmaceuticals and biologics. Scalable innovations to advance and strengthen biomanufacturing supply chain and resolve bottlenecks including:o Advances in production of active pharmaceutical ingredients, process consumables, and other critical materials (i.e., enzymes, cell lines, etc);o Novel biomanufacturing-related data products, technologies or models to integrate into supply chain situational awareness systems;o Alternative materials and new manufacturing capabilities for personal protective equipment; ando Improvement of capabilities sustainably re-shore manufacturing and utilize a broad array of readily accessible and cost-efficient feedstocks as part of strengthening the local and national industry base. Analytics and novel sensor systems to precisely manage bioproduction, real-time release assays, and predictive capabilities to inform tuning of biological chassis for efficient and effective scale-up of manufacturing to industrial scale.*ARPA-H is not interested in approaches that merely increase capacity reservation.Other high-quality submissions that propose revolutionary technologies that meet the goals of SSO will be considered even if they do not address the topics listed above.Proposals are expected to use innovative approaches to enable revolutionary advances in medicine and healthcare, and the science and technology underlying these areas. While approaches that are disease agnostic are encouraged, ARPA-H welcomes proposals that bring radically new insights to address specific diseases including, but not limited to, cancer, diabetes, neurological diseases, pediatric and maternal/fetal health, infectious diseases, and cardiovascular disease.Specifically excluded are proposals that represent an evolutionary or incremental advance in the current state of the art or technology that has reached the clinical trial stage. An example of this type of proposal might include the request to fund clinical trials of an otherwise developed product. Additionally, proposals directed towards policy changes, traditional education and training, or center coordination, formation, or development, and construction of physical infrastructure are outside the scope of the ARPA-H mission.

The United States Agency for International Development (USAID) is seeking applications for a Cooperative Agreement with a Total Estimated Amount of $45,000,000 from qualified entities to implement the program entitled Strengthening Integrated Health Services Activity (SIHSA) in Sierra Leone.USAID anticipates awarding a five-year cooperative agreement (CA) to advance and sustain improved health outcomes for Sierra Leoneans with a focus on, but not limited to: children under five, pregnant and postpartum women, youth and especially adolescent girls, and women and children living in hard-to-reach areas with limited access to health services. Special attention will be paid to those especially vulnerable within these groups, such as the disabled, gender andsexual minorities (GSM), and ethnic and religious minorities.SIHSA seeks to build a sustainable and resilient health system response to improving access, quality, and effectiveness of family planning (FP), reproductive health (RH), maternal, newborn and child health (MNCH), adolescent health, and malaria services. In addition, SIHSA aims at strengthening communities;apos; active engagement for community-driven solutions to improve health outcomes. Finally, SIHSA seeks to promote a paradigm shift within the health system, supporting system-wide action, especially at community and district levels, including reforms that act on the foundations of the health system and create opportunities for partnering with the local civil society and private sector for improved health outcomes.

The Food Security Infrastructure Grant (FSIG) Program seeks to ensure that farmers, commercial fishermen, and other local food producers are better engaged with a strong, resilient food system to help mitigate food supply and distribution disruptions, as well as to ensure that individuals and families throughout the Commonwealth have equitable access to food, with a focus on food that is produced locally. Donor Name: Massachusetts Department of Agricultural Resources State: Massachusetts County: All Counties Type of Grant: Grant Deadline: 05/02/2024 Size of the Grant: $100,000 to $500,000 Grant Duration: 1 Year Details: Projects to enhance equitable access to food for individuals and families throughout the Commonwealth, with a focus on food that is produced locally. The FSIG program (“Program”) also seeks to ensure that farmers, fisherman, and other local food producers are better connected to markets in a strong, resilient food system, and that they have the infrastructure needed to produce and distribute healthy food efficiently and safely. Providing greater, more equitable access to local food and strengthening the role of local food in the Commonwealth’s food system is an important goal of the Program. Local food is defined through this Program as food which is grown/produced and distributed within the Commonwealth. The local food system is a network of consumers, workers, businesses, owners, and supporting organizations engaged in an array of activities, including fishing, farming, preparing, marketing, distributing, serving, and eating food. This network works to produce and distribute food that nourishes the communities, sustains businesses and workers, and supports responsible stewardship of the land, water, and other natural resources. Funding Information Part I: Agriculture Maximum funding per applicant $500,000. Part II: Local Food System Maximum funding per applicant $500,000. Grant Period July 1, 2024 to June 30, 2025. Eligible Projects  Eligible projects must be capital improvements including the purchase of equipment and contracted labor costs in order to implement projects, or costs associated with planning and design directly related to capital projects that will allow applicants to strengthen and improve the resiliency of the Commonwealth’s food system while allowing greater access to fresh, local food in a way that addresses systemic inequities. Eligibility Criteria  Applicants may be individuals, for-profit, or non-profit entities. Municipalities and other governmental entities may also be eligible to apply, provided all necessary requirements to submit an application can be met, the ability to utilize funding can be demonstrated, and the entity has the ability to enter into a contract with MDAR. For more information, visit MDAR.

The Massachusetts Food Ventures Program (MFVP) is designed to increase access to healthy, affordable food options and improve economic opportunities for low to moderate income communities. Donor Name: Massachusetts Department of Agricultural Resources State: Massachusetts County: All Counties Type of Grant: Grant Deadline: 05/06/2024 Size of the Grant: Not Available Grant Duration: Grant Duration Not Mentioned Details: The MFVP will provide funding through grants to support food ventures, sited primarily in or near communities of low or moderate income, including Gateway Cities and rural communities. The MFVP will help implement goals of the Massachusetts Local Food Action Plan and contribute to the financing needs of local Massachusetts food enterprises.  With expanded investment, completed projects will improve access to Massachusetts grown, harvested or caught food products through the development of collaborations with local agricultural enterprises and private/public entities. Key areas for investment include: food processing infrastructure to meet the needs of the expanding local food system; improved distribution systems to support opportunities for equitable access to fresh local food; and retail outlet strategies that enhance access to healthy food. The following are examples of potential, eligible Food Ventures projects Food Processing Infrastructure – Creation of commercial food processing infrastructure to ensure availability of Massachusetts produced foods and which can benefit low and moderate income households. Non Retail: Food Commissaries – Innovative proposals by commercial food commissaries that connect local farms and partners, create new local food retail markets or improve marketing within low income communities. Proposals may include requests for support for infrastructure, distribution, processing and marketing plans that demonstrate increased access to low to moderate income communities. Food Co-Ops – Proposals for construction, renovation or build-out of existing facilities that will create new permanent jobs and/or  greater access to affordable, fresh food. Greenhouses and Farmers’ markets – Develop and build facilities designed to increase year round access of diverse food production and distribution to existing or new markets to benefit low to moderate income communities. Food Hubs – Capital for infrastructure to build or renovate sites for new or existing ventures that improve commercial food access in low to moderate income communities. Commercial Markets – Innovative projects that connect local food producers and partners in order to develop, build or renovate a large scale retail market, designed to improve commercial distribution of healthy, locally produced food. Proposals may include initiatives for new construction or the renovation of an existing building. Must clearly document a community demand and outline a marketing strategy for expansion of commercial food access and distribution in low to moderate income areas. Mobile Markets/Innovative Markets – To purchase, design, and upgrade vehicles to provide healthy Massachusetts food including meats, seafood, vegetables, and fresh or frozen produce for purchase. Must provide marketing strategy that demonstrates the expansion of commercial access and distribution in low to moderate income communities. Who May Apply? Massachusetts Municipalities. Massachusetts Non-Profit or For-Profit Organizations. Individual Residents of Massachusetts. Examples of ineligible project areas: Funding for audits, feasibility studies or design work. Operation or maintenance costs associated with the proposed grant investment. Staff or consultant time on proposals for projects that have already been completed or for which the applicant seeks reimbursement. For more information, visit MDAR.

The Opioid Abatement Fund Council (OAFC) seeks to combat opioid overdoses in Texas by awarding funds to implement a statewide program that will distribute the opioid overdose reversal medication naloxone where it is needed most, and provide related training, including airway clearance techniques. The Texas Legislature created the OAFC in 2021 to ensure funds collected through lawsuits against pharmaceutical companies are used fairly and efficiently to combat the opioid crisis in Texas. The OAFC is made up of 13 appointed experts and the Texas Comptroller of Public Accounts (CPA) as the non-voting presiding officer. Grant Amount: Up to $25 million Up to $25 million is available for this grant opportunity: approximately $18.75 million for the purchase of naloxone and providing related training, with nearly $3.13 million for administrative costs and another $3.13 million for interventions in targeted counties. The expected term of the grant agreement is an initial two years, with three possible two-year renewal periods for a total project length of eight years. The grant recipient will receive funds on a reimbursement basis. Eligibility Texas governmental entities, nonprofit organizations and any entity registered with the Texas Secretary of State and eligible to conduct business in Texas are eligible to apply. Funding will be awarded to one applicant to implement the program statewide, but applicants may use qualified subcontractors or subgrantees. Companies that paid funds or currently are involved in opioid abatement lawsuits are disqualified from applying. Applicants and subcontractors must also not be subject to the general disqualifications, such as being included on the CPA debarred vendor’s list or having a conflict of interest with the OAFC. Grant applicants may submit a written request for CPA’s preliminary review of any potential conflict of interest by March 18, 2024, to [email protected]. Application and Award Process Applicants must complete an application form, including fully developed and detailed proposals and budgets, through the OAFC’s grant management system by May 7, 2024. The internet browser that works best with the grant management system is Google Chrome. A mobile app is also available. Applications will go through a multi-stage selection process, including a risk review and evaluation by an independent peer review panel. After the review process is complete, the OAFC will vote on the final grant award. The grant recipient will be required to submit timely detailed status reports that cover the grant recipient’s and any subgrantee’s performance, expenditures and any additional information requested by the OAFC. CPA may also conduct site visits during the project and after project completion to monitor progress and assess the effectiveness of the program.

The Illinois Department of Commerce and Economic Opportunity (the “Department” or “DCEO”) is issuing this Notice of Funding Opportunity (“NOFO”) to provide grant funding for establishment of an incentive grant program used by eligible entities to attract new out-of-state events to Illinois when competing with other states’ destinations. Donor Name: Illinois Department of Commerce & Economic Opportunity State: Illinois County: All Counties Type of Grant: Grant Deadline: 05/01/2024 Size of the Grant: More than $1 million Grant Duration: 5 Years Details: The program can be developed at the local level and may include, but not limited to: Event space/venue rental: Room rental, event staging – build, setup, trussing, lighting, pipe and draping, power and sound, security, traffic control. If the applicant is a venue that owns the facility and controls any assets outlined in this example those costs are not allowable. Event rentals: Tables, seating, décor, tents, dinnerware, flatware, glassware, linens Food/Beverage: Meals, beverages (excluding alcoholic beverages), service labor fees Audio/Visual Support: Microphones, screens/projectors, other specialized equipment, internet access, service labor fees Entertainment (as part of an otherwise planned event): Speakers, DJs, performing acts Registration & Event Management: Event management technology software that handles online event registration; virtual, hybrid and onsite solutions and attendee engagement Transportation: Shuttle service provided to move overnight guests to and from the event/venue space on a master account (individual guest receipts are not eligible). Shuttle service to pick up overnight guests at the airport and drop them off at the hotel and vice versa upon the conclusion of the meeting/event; this is for guests on a master account as individual guest receipts are not eligible. Bid fees associated with attracting a new event to Illinois Room night credits that are actualized, contracted, revenue-generating group room nights directly sourced by the bureau and must exceed 300 for outside the City of Chicago and 5000 for the City of Chicago Performance Goals and Measures Program goals or performance measures must include, but not limited to: Estimated hotel room nights booked as a result of the events. Economic impact of the events. Attract or retain events to Illinois that would not have otherwise occurred in Illinois. Funding Information Total amount of funding expected to be awarded through this NOFO is $15,000,000. Awards will range from $50,000 to $5,000,000. Project Period The period of performance is expected to be January 25th, 2024 through January 31st, 2029. Eligibility Criteria An entity must be registered in the Grant Accountability and Transparency Act (GATA) Grantee Portal, at the time of grant application. The portal will verify that the entity: Has a valid FEIN number Has a current SAM.gov registration, SAM.gov registrations must be marked as “public” to allow the GATA Grantee Portal to expedite the review of the federal information; Has a valid UEI number Is not on the Federal Excluded Parties List Is in Good Standing with the Illinois Secretary of State Is not on the Illinois Stop Payment list Is not on the Department of Healthcare and Family Services Provider Sanctions list Eligible Applicants include Unit of local government Local promotion group, Not-for-profit organization; For-profit organization; Convention center authority For more information, visit DCEO.

This grant provides funding to support promising postdoctoral researchers in neuroscience, enabling them to receive advanced training and mentorship in a focused research environment.

This program provides funding to establish community-based telehealth resources that connect rural veterans with healthcare providers, improving their access to essential medical services.

This opportunity seeks input from organizations involved in maternal and child health projects to help improve healthcare quality for the poorest and most vulnerable populations in Indonesia.

This grant provides funding to U.S. institutions to create programs that train future physician-scientists, equipping them with both medical and research skills to advance biomedical research and improve healthcare.